Biotech stocks are very volatile as they are driven by clinical trial data and regulatory decisions. Let's take a look at the companies that are scheduled to report/update their clinical trial results this week.
from RTT - Biotech https://ift.tt/2Am79nO
via IFTTT
No comments:
Post a Comment